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Abstract  
HIV-1 virions assemble as immature particles containing Gag polyproteins that 
are processed by the viral protease into individual components, resulting in the formation 
of mature infectious particles. There are two competing models for the process of 
forming the mature HIV-1 core: the disassembly and de novo reassembly model and the 
non-diffusional displacive model. To study the maturation pathway, we simulate HIV-1 
maturation in vitro by digesting immature particles and assembled virus-like particles 
with recombinant HIV-1 protease and monitor the process with biochemical assays and 
cryoEM structural analysis in parallel. Processing of Gag in vitro is accurate and efficient 
and results in both soluble capsid protein and conical or tubular capsid assemblies, 
seemingly converted from immature Gag particles. Computer simulations further reveal 
probable assembly pathways of HIV-1 capsid formation. Combining the experimental 
data and computer simulations, our results suggest a sequential combination of both 
displacive and disassembly/reassembly processes for HIV-1 maturation. 
Introduction 
Formation of the infectious Human Immunodeficiency Virus (HIV-1) particle 
occurs via two processes: the assembly of spherical immature particles that are non-
infectious, as the virus buds out at the plasma membrane, followed by maturation of the 
viral core 1. During maturation, the viral protease (PR) cleaves the Gag polyprotein into 
its constituents: matrix (MA), capsid (CA), nucleocapsid (NC), and p6, thereby also 
releasing the SP1 and SP2 peptides 2. The interaction between the positively charged NC 
domain and negatively charged RNA 3, in particular the 5’ UTR, is responsible for the 
encapsidation of the RNA genome within particles. Protein-protein interactions between 
CA domains are the driving force for Gag assembly in the immature hexagonal lattice 4,5 
as well as for CA assembly in the mature capsid 6-8. Previous computer simulations and 
theoretical studies have revealed key features of CA self-assembly into conical mature 
HIV-1 capsids 8-14.  
HIV-1 maturation occurs in multiple stages 15. Following the first cleavage 
between SP1 and NC, the NC-RNA complex condenses into a dense material. 
Subsequent cleavage at the MA-CA junction liberates MA and frees CA-SP1 from 
membrane attachment. The slowest cleavage is the release of SP1 from the C-terminus of 
CA 15-17. Proteolytic maturation is essential for infectivity, and PR inhibitors are a key 
element of current antiretroviral therapies 18. A potent maturation inhibitor, Bevirimat 
(BVM), blocks CA-SP1 cleavage and prevents formation of the mature conical capsid 19-
22. Recent structural and mutational studies have indicated that the junction between CA 
and SP1 could act as a molecular switch to regulate immature Gag assmebly and protease 
cleavage 23-26. Structural analyses of the Gag lattice in mutant viruses that have impaired 
cleavage of Gag at specific sites suggest that processing is ordered and that the 
RNA/protein complex (RNP) may maintain a link with the remaining Gag lattice after 
cleavage 27. 
While the architectures of immature and mature virions are well characterized 5-
8,28,29, the pathway of maturation and the morphological transition process is not well 
understood. Recent studies have led to two distinct, competing models for the 
transformation of immature spherical virions to mature virions with conical cores, namely 
the disassembly/reassembly model and the displacive model 4,27,30-33. In the 
disassembly/reassembly model, the immature lattice disassembles following PR cleavage, 
generating a pool of soluble CA molecules from which a mature capsid assembles de 
novo. Several previous studies provide support for this model. Firstly, based on early 
cryo-electron tomography (cryoET) observations of 1) virus-like particles (VLPs) with 
multiple capsids, 2) mature capsids with tip closing defects 34, and 3) a correlation 
between capsid length and membrane diameter 28, models of capsid growth, from either 
the “narrow end” 34 or the “wide end” 28 of the capsid, have been proposed. Secondly, 
structural studies revealed distinct lattice spacings and different interaction interfaces 
between the immature and the mature CA lattices, suggesting the transition involves a 
complete disassembly of the immature lattice 4,35. More recently, cryoET of maturation 
inhibitor BVM-treated virions displayed a shell that resembles the CA layer of the 
immature Gag shell but is less complete 21. Lastly, cryoET of budded viral particles 
comprising immature, maturation-intermediate, and mature core morphologies suggested 
that the core assembly pathway involves the formation of a CA sheet that associates with 
the condensed RNP complex and further polymerizes to produce the mature conical core 
33.  
By contrast, the displacive transformation model postulates that maturation 
involves a direct, non-diffusional remodeling of the immature Gag lattice to the mature 
capsid lattice 30,32. In this model, the immature lattice does not disassemble to form the 
mature one. Evidence for a displacive model includes: 1) PR cleavage of in vitro 
assembled CA-SP1-NC tubular assemblies resulted in conversion to mature CA tubes 
without disassembly 32; 2) mutant particles with a cleavage defect at the CA-SP1 site 
have thin-walled spheroidal shells with lattices displacively transformed into a mature-
like lattices 31; and 3) recent cryoET observation of multiple, normal-sized cores within a 
large membrane enclosure, which argues against de novo nucleation and assembly model 
and suggests a rolling sheet process for CA lattice transformation to conical capsid 30.  
To examine the sequence of structural changes that take place during maturation, 
we establish novel in vitro cleavage systems that mimic the maturation process, by 
digesting purified PR-deficient virions and in vitro assembled Gag VLPs with 
recombinant HIV-1 PR. We further investigate the effects of BVM and Gag cleavage 
mutants on the in vitro maturation process. Using computer simulation, we reveal the 
impact of membrane and genome on mature capsid formation. Integrating our 
biochemical and structural findings from the in vitro maturation experiments with 
computer modeling and simulations, we conclude that the HIV-1 maturation pathway is 
neither simply displacive nor exclusively de novo reassembly, but a sequential 
combination of both displacive and disassembly/reassembly processes.  
 
Results 
In vitro maturation by HIV-1 PR cleavage  
To study the structural transitions occurring during HIV-1 maturation, we first 
established a novel in vitro system to mimic the PR-driven HIV-1 maturation process by 
digesting purified PR-deficient immature virions with recombinant HIV-1 PR. The viral 
membranes of immature particles were permeabilized with Triton X-100 to allow 
recombinant HIV-1 PR access to the viral structural polyproteins. The sequential 
processing of Pr55gag by PR into its constituents in the in vitro maturation system closely 
mimicked that of native virions (Fig. 1). Gel analysis of the PR-treated particles revealed 
efficient release of MA, CA, and NC in a time-dependent manner, consistent with the 
process seen in native virion maturation 15. The PR cleavage was also pH dependent, 
most efficient at pH 6.0, at which almost all polyproteins were cleaved into CA in 2 hrs at 
37°C (Fig. 1a), whereas the majority of CA-SP1 remained intact at pH 7.5. Furthermore, 
cleavage at the CA-SP1 junction was inhibited by the maturation inhibitor BVM (Fig. 1b), 
indicating that the immature particles are of the correct structure for binding the inhibitor 
36. Moreover, the MA-CA cleavage site was apparently partially protected by BVM (Fig. 
1b), an effect that was not previously observed during HIV-1 maturation 37,38. The overall 
cleavage pattern of Pr55gag by PR, observed in this system, suggested that this system 
could prove useful for mimicking the process of HIV-1 maturation in vitro.	
In parallel, we established a unique system for in vitro maturation of assembled 
Gag VLPs, using entirely purified recombinant protein components. Immature VLPs 
were assembled from recombinant Gag protein lacking p6 and most of the MA regions 
(DMA15-100Dp6) together with RNA. We tested the cleavage efficiency with various HIV-
1 PR concentrations (Fig. 1c). Under the experimental conditions at pH 6.0, the cleavage 
process was completed within 2 hrs in the presence of 3.3 µM PR (Fig. 1c), agreeing well 
with the results obtained from immature virions (Fig. 1a). As with the immature virions, 
the process was also time-dependent (Fig. 1d); cleavage between CA-SP1 was slow, and 
all CA was released within 2 hrs in the presence of 3.3 µM PR. Intriguingly, the effect of 
BVM was pH-dependent, with a strong effect at pH 7.4 but a marginal effect at pH 6.0 
(Fig. 1e). The CA-SP1 cleavage process was nearly complete at pH 6.0, despite the 
presence of a high concentration of BVM (40 µM), whereas a majority of CA-SP1 
remained intact at pH 7.4. The same pH-dependent BVM activity pattern was also 
observed with immature virions. It should be noted that the efficiency of CA-SP1 
cleavage was also reduced at pH 7.4 compared to pH 6.0 (Fig. 1e), as seen with immature 
virions (Fig. 1a). Taken together, these data indicate that both in vitro PR cleavage 
systems recapitulate the HIV-1 maturation process, providing useful tools for 
characterizing the effects of maturation inhibitors. 
 
CryoEM analysis of in vitro maturation process  
To investigate the structural changes upon HIV-1 PR cleavage, we carried out 
cryoEM analysis of the in vitro maturation process described above. The PR-deficient 
immature virions appeared as membrane-bound spheres of variable sizes, about 100 nm 
in diameter (Fig. 2a). The Gag lattices, lining the inside of the membrane, were clearly 
apparent (Fig. 2a inset, arrow). Limited detergent treatment of immature virions resulted 
in nonhomogeneous membrane perforation of immature virions (Fig. 2b). Within a single 
virion, part of the viral membrane became punctured (Fig. 2b and inset, black arrow), 
while other areas of viral membrane remained intact (Fig. 2b and inset, black arrowhead). 
In fact, most of the immature particles were broken or fragmented upon mild detergent 
treatment typical for isolating cores 39 (Fig. 2b). When the concentration of Triton X-100 
was reduced to its critical micellar concentration (CMC) of 0.02%, we observed, within 
membrane enclosed particles, conical structures with an apparent ordered lattice (Fig. 2c), 
in addition to some ordered densities on the membrane facing outwards that only appear 
in the protease-treated samples (Fig. 2c, black arrows).  
Can such a transition from an immature lattice to a mature lattice take place 
without membrane and any host cell factors or other viral proteins? To address this 
question, we employed our all recombinant and reconstituted in vitro maturation system 
and carried out cryoEM analysis of PR-treated Gag VLPs from the same samples 
analyzed biochemically (Fig. 1c and d, marked with “*”). In the presence of yeast tRNA 
(10% w/w), purified recombinant Gag polyprotein assembled very efficiently into 
spherical particles about 100 nm in diameter with well-ordered surface lattices (Fig. 2d 
and g). The particles were stable and remained intact after 2 hrs incubation with digestion 
buffer (Fig. 1c “*1”, Fig. 2d and g). Upon completion of PR digestion (Fig. 1c “*3”), 
large clusters, comprising numerous cleavage products, were present (Fig. 2f), in stark 
contrast to the entirely monodispersed initial Gag VLPs (Fig. 1c “*1”, Fig. 2d). 
Remarkably, the clustered cleavage products formed conical or tubular shaped assemblies, 
resembling the mature-like structure (Fig. 2i, red arrows), with a cone to cylinder ratio of 
57%. Some “hybrid” entities were occasionally observed (Fig. 2i, black arrows, 
Supplementary Fig. 1), suggesting an incomplete maturation process. We also imaged 
samples processed with a lower PR concentration (Fig. 1c “*2)”. Not surprisingly, we 
found fewer cones and tubes and more incompletely cleaved particles (Fig. 2e and h, 
Supplementary Fig. 1), compared to the sample that underwent cleavage to completion. 
These data suggest that the transition from immature Gag sphere to mature-like conical 
CA structure can occur without host cell factors, viral membrane or viral proteins other 
than Gag and PR. Purified CA protein can assemble into cones and tubes in vitro, but this 
requires high protein concentration (>80 µM) and very high salt (>1M NaCl) 8. Given the 
relatively low CA concentration (37 µM) and very low salt (near 0 µM NaCl) in our 
cleavage reactions, de novo assembly of cleaved CA into these structures is unlikely. 
Taken together, these results support, at least in part, a displacive maturation pathway 
rather than the disassembly and reassembly process 30,32. 
 
CryoEM structures of Gag VLPs and maturation product 
To confirm that the assembled spherical Gag VLPs do indeed have an immature 
lattice whereas the final cleavage products have mature-like structures, we obtained 3D 
density maps of these assemblies by cryoEM. Using cryoET and sub-tomogram 
averaging 4,5,40, we obtained a 3D density map of Gag VLPs (Fig. 3a) to 18.4 Å resolution 
by gold-standard Fourier shell correlation (FSC). As shown in Fig. 3b and c, at this 
resolution, the averaged density map clearly displayed an immature configuration, 
overlapping well with the previously published immature HIV-1 structure 5. Docking of 
the immature structural model 4USN 5 into our density map exhibited a very good fit (Fig. 
3b and c), with a cross correlation coefficient of 0.81. Therefore, the assembled Gag 
VLPs used for in vitro maturation are indeed in the immature lattice arrangement. 
Upon PR cleavage of Gag VLPs to completion (i.e. all Gag molecules converted 
to CA, Fig. 1c “*3”), we observed a small fraction of long tubes that were amenable for 
structural analysis (Fig. 3d), along with numerous conical or short tube-shaped structures 
(Fig. 2f and i). Combining the segments from the tubes with the same helical symmetry 
and using a single particle real space helical refinement approach 8,41, we obtained a 3D 
reconstruction, at 22 Å resolution, of the tubular products that resulted from PR cleavage 
(Fig 3e-g). In contrast to the undigested precursor, the tube density map showed an 
entirely mature-like conformation (Fig. 3e), with hexameric CA subunits arranged in 
helical arrays, as seen in mature CA assemblies 8. The mature CA structural model 3J34 8 
fitted into the density map very well, further confirming that the tubes have a mature CA 
conformation. In contrast, docking the mature hexamer 3J34 into the undigested 
(immature) map and the immature hexamer 4USN into the digested (mature) map 
resulted in very poor fitting, with cross correlation coefficient values of 0.39 and 0.4, 
respectively (Supplementary Fig. 2). More interestingly, unlike our previous in vitro CA 
tubular assembly, additional densities, likely corresponding to the released NC and RNA, 
appeared inside these tubes. A similar NC and nucleic acid release concurrent with 
formation of mature CA tubes, without CA dissociation, was previously observed upon in 
vitro PR cleavage of CA-NC assemblies 32.   
 
CA association following Gag cleavage 
We observed only a few conical shaped structures upon in vitro cleavage of PR-
defective immature virions (Fig. 2c), a surprising result considering the large number of 
starting immature particles. One plausible explanation for this paucity of cores is 
dissociation of CA molecules from the particles upon cleavage. To test this, particles 
were pelleted after PR digestion and particle-associated CA was detected by 
immunoblotting. As shown in Fig. 4a, a significant amount (more than 1/3) of CA and 
CA-SP1 remained pelletable, i.e. was associated with the particles or formed aggregates, 
during the in vitro maturation process, after NC and MA were cleaved from Gag. Given 
that the viral membranes were permeabilized to allow PR to enter viral particles, which 
would also allow free CA to leave, the particle-associated CA may have arisen from 
either conversion from immature lattice without dissociation, or via a 
disassembly/reassembly process. If cleaved CA molecules dissociated from the lattice 
and reassembled into mature capsid, one might expect from this de novo assembly model 
that capsid-destabilizing mutations and capsid assembly inhibitors would affect the 
reassembly process and thus inhibit mature capsid formation. We thus investigated the 
effect of capsid-destabilizing mutation K203A, which does not assemble into tubes in 
conditions that wild-type does, on CA association following Gag cleavage. As shown in 
Fig. 4b, the K203A CA mutation did not reduce the fraction of CA that remained 
pelletable following PR treatment. Similarly, the capsid assembly inhibitor CAP-1 did 
not inhibit the in vitro maturation process (Fig. 4c). These studies suggest that maturation 
could occur via conversion of the immature lattice to the mature lattice without requiring 
dissociation of the CA subunits. 
On the other hand, in vitro cleavage of Gag VLPs yielded very little associated 
CA in the pellets (Fig. 4d, wt), in contrast to the PR-deficient immature particles (Fig. 4a). 
In fact, more than 95% of the CA dissociated from the particles and was released into 
solution (Fig. 4d, wt), consistent with the observed infrequent occurrence of the clustered 
cleavage products in Fig. 2f and i, seemingly suggestive of a disassembly model. To 
further investigate the process of in vitro PR cleavage of Gag VLPs, we purified Gag 
proteins carrying substitutions that prevent cleavage at the MA-CA (Y47I mutation in the 
construct used, or	Y132I in the context of full length Gag) and CA-SP1 (L278I/M282I 
mutations, or L363I/M267I in full length Gag) junctions 42. Like the corresponding wild 
type Gag protein, both mutant proteins efficiently assembled into spherical particles. PR 
treatment of the assembled Gag mutant VLPs yielded the expected cleavage products, 
MA-CA and CA-SP1, with more than 95% of MA-CA and CA-SP1 in the soluble 
fraction, as seen for CA in the wild-type VLPs. By contrast, the NC protein released from 
the wild type Gag protein and both Gag mutants was found in the pellet fraction (Fig. 4d). 
These studies suggest that the cleavage products, CA, MA-CA and CA-SP1, can 
dissociate from the particles after removing NC and RNPs.   
 
Role of membrane and genome in the formation of mature core 
The conversion of spherical immature particles into conical and tubular CA 
assemblies, together with the observed dissociation of CA molecules from particles upon 
cleavage, appears to support some aspects of both de novo assembly and simple 
displacive models. We used computer modeling and simulation to explore the underlying 
physical mechanisms and constraints that are relevant to capsid assembly. 
Building upon our previous simulation work 43-46, we used a simple model of viral 
capsid growth to first investigate the physical impact of the virion membrane on the 
formation of cylindrical or conical shells.  We modeled the membrane as a spherical case, 
which sets a constraint for the shell growth such that the subunits remain within a sphere 
of radius, rm .  In the model, the membrane-subunit interaction is described as a potential 
for an interior soft wall, dim - rm( )
2
i
∑ , if rm < dim , with dim  the distance between the ith   
vertex of the subunit and the center of the sphere, and the potential vanishes for subunits 
within the radius rm .  As shown in Fig. 5, the membrane restricts the growth of the 
otherwise extended incomplete shell (Fig. 5a) and induces local stresses causing 
formation of the pentamers necessary for the assembly of closed conical or tubular shells 
(Fig. 5b). We note that the limiting effect of membrane on capsid height was reported by 
Briggs et al. 28. Their data suggest that the cone assembly is initiated at the narrow tip and 
stops growing when it reaches the membrane at the wide base. While our results agree in 
that membrane limits the growth, our simulations indicate a different pathway (see 
Supplementary Movies 1-6). More interestingly, we found that the membrane could exert 
a force on the growing sheet that breaks the symmetry and causes the shell to grow as a 
cone rather than a cylinder (Supplementary Movie 1). Statistical analysis of 300 
simulations showed that the frequency of forming a conical shell increased to 52% when 
constrained in the membrane compared to 37% without the membrane (Supplementary 
Table 1) suggesting that the virion membrane promotes conical shell formation. 
To explore the impact of the genome (or RNP) on shell formation, we modeled 
the genome as a soft ball, due to steric interactions, with the interaction between the 
genome and the shell presented through the potential, dig − rg( )
2
i
∑ , if rg > dig , with rg  the 
radius of gyration of the genome (soft ball) and
 
dig  the distance between the ith  vertex of 
the subunit and the center of the genome. This potential keeps the subunits outside of the 
ball. If rg < dig , no interaction occurs between the genome and protein subunits (CA). We 
emphasize that the focus of our simulations is on the role of RNA-NC complexes in the 
formation of conical vs. cylindrical shells, and, as such, the soft ball is a good 
approximation for RNA only after NC cleavage. 
We considered the impact of the genome by employing two different models. In 
the first model, we assumed that a few subunits are attached to the genome but the 
complexes of the genome-subunits are free to move inside the membrane. If the genome 
remains attached to the growing sheet during the initial stages of the growth process, the 
conical shell forms with the genome inside (Fig. 5c, Supplementary Movie 2). If the 
genome detaches from the growing shell early in the growth process, a cylindrical shell 
forms with the genome outside (Fig. 5c, Supplementary Movie 3). As shown in 
Supplementary Table 1 and Supplementary Fig. 7, the presence of the genome increased 
the frequency of cone appearance to 83%, approximately similar to the previously 
observed cone frequency of 95% 47. 
In the second model, we kept the genome-subunit complexes attached to the 
membrane during the growth process until about one-sixth of the capsid had formed, at 
which point, we released the genome-subunit complex. The simulations show that the 
hexagonal sheet continues to grow asymmetrically along one side of the shell until it 
meets the membrane, which exerts a force on the shell and makes it roll and grow back 
towards the RNP (Supplementary Fig. 3, Supplementary Movie 4).  Similar to the first 
model, if the genome is attached to the growing shell, more conical capsids with genome 
inside occur, while, if the genome detaches, cylindrical capsids form with the genome 
outside.  In both models, the initial attachment of the genome to the growing shell is 
important for the formation of a conical shell. 
 
A combination of displacive and  disassembly/reassembly pathways 
We further investigated capsid formation from a partially formed shell while in an 
immature state at the time of release from the membrane. Based on the displacive model, 
we considered that the sheet of capsid proteins retains the same connectivity as Gag 
proteins in the immature virion.  We assumed that the subunits in the immature sheet, 
containing as many as 600 subunits, undergo some conformational changes without 
disassembly resulting in their preferred dihedral angle and flexibility similar to the 
mature shells. The simulation shows a large sheet of subunits attached to the surface of 
the spherical membrane and growing. The sheet then detaches from the membrane and 
subsequently rolls around the genome. Finally, the sheet grows into a closed conical shell 
in a process identical to the de novo assembly model described above (Fig. 6, 
Supplementary Movie 5).  The outcome of these simulations depended upon the size of 
the initial immature sheet. For large sheets with around 600 subunits or larger, we 
observed a decrease in the efficiency of cone formation and an increase in the occurrence 
of defective cones and cylinders. The sheets with a smaller number of subunits in the 
initial immature lattice have a much higher probability to grow to cones without defects. 
When we decreased the number of subunits in the initial “immature” lattice to 400, the 
lattice rolls around the genome but is not large enough for the two edges to merge 
immediately. Addition of free CA subunits to the growing sheet results in the formation 
of cones with almost no defects (Supplementary Fig. 4 and Supplementary Movie 6). In 
fact, simulation results did not support a direct conversion from the complete immature 
lattice, as suggested by a simple displacive model. Thus, we conclude that a probable 
pathway for the formation of conical shells, is a sequential combination of displacive 
rearrangement and growth. Starting with a partially formed immature sheet has the 
advantage that the entire lattice does not need to disassemble and reassemble; however, a 
diffusive growth phase appears to be necessary to minimize assembly defects. 
 It is important to note that we also carried out a number of simulations in the 
absence of membrane but in the presence of genome to study the combinatory pathway in 
situations in which the membrane has been completely removed, as in the case of some 
experiments. The conical shells were still formed (Supplementary Fig. 5) consistent with 
the experiments.  
 
Discussion 
Previous studies have led to two competing HIV-1 maturation models, the de 
novo disassembly-and-reassembly model and the lattice displacive model, for the 
conversion of immature Gag lattice to mature conical capsid. In an effort to distinguish 
between these HIV-1 capsid maturation models, we devised in vitro PR cleavage systems 
to mimic HIV-1 maturation and monitored the maturation process with biochemical and 
structural analysis, as well as computer simulations. The results presented in this study 
challenge aspects of both existing models. Based on our in vitro maturation data and the 
computer modeling results, we propose a sequential process for maturation in which 
capsid assembly is initiated by displacive remodeling and capsid growth occurs via 
soluble subunit addition.  The model is illustrated in Figure 7.   
Our results suggest that the de novo assembly model cannot be the sole pathway, 
given that in vitro PR cleavage of Gag VLPs resulted in conical shaped structures under 
conditions that do not support assembly of soluble CA molecules into conical or tubular 
structures 8,47. Consistent with a recent cryoET study with large membranes enclosing 
multiple capsids 30, the size of Gag spheres, rather than the viral envelope membrane, 
which is absent in our in vitro Gag VLP system, determines the size of the mature capsid. 
These data are in conflict with the complete de novo disassembly/reassembly model 
which predicts that the mature core begins to grow at its narrow or wide end, from 
nucleation of CA units on one face of the membrane, and stops growing when it reaches 
the boundary of the membrane on the opposite side 28,34. Furthermore, our study, as well 
as two recent cryoET analyses 30,33, have identified the formation of CA sheet-like 
structures as an intermediate during the maturation process. While Woodward et al. 33 
interpreted this as a de novo CA assembly product, data from our and Frank et al.’s work 
30 suggest that these initial CA sheets form through a displacive process. In addition, 
HIV-1 particles with functional MA-CA cleavage but defective CA-SP1 cleavage (CA5 
particles) exhibit a layer morphology that is consistent with the structure of the mature 
CA lattice 15,21,27, indicating that the CA-SP1 layer is formed upon release from the 
membrane and that it is unlikely that most of the CA dissociates from the lattice prior to 
capsid assembly. Moreover, in our in vitro PR cleavage assays, capsid-destabilizing 
mutations and capsid assembly inhibitors had little effect on CA association, further 
arguing against the simple de novo reassembly model.  
On the other hand, our results also argue against an entirely displacive model, as 
suggested by Frank et al 30, given our observations that a major fraction of CA and CA-
SP1 are indeed dissociated from the Gag lattice during in vitro PR cleavage of Gag VLPs 
lacking membrane. If the capsid is formed exclusively by the non-diffusional phase 
transition of immature to mature CA lattice, one would expect to find that the stress and 
deformations inherent in this process result in defects in the mature CA lattice. In fact, 
our computer simulations failed to yield a closed mature core when employing only the 
non-diffusional phase transition (Supplementary Movie 7), as the transformation of an 
elastic sheet to a closed conical shell requires disassembly of many subunits at the 
growing edge and inclusion of pentamers in the “right” position for the shell to close 
properly. Therefore, based on our experimental data and computer simulation results, we 
propose a combinatory pathway for HIV-1 capsid maturation, which begins with non-
diffusional transition and followed by CA dissociation and growth.  
This sequential displacive rearrangement and growth model is consistent with 
nearly all the previous experimental observations. An assembly pathway involving both 
displacive and de novo modes is advantageous as a part of the shell is already built and 
does not need to reassemble from scratch. The model further implies that the viral 
membrane, MA and the RNP likely guide the capsid assembly pathway 33,48. Interestingly, 
a recent cryoET study revealed that viral particles with the NC-SP2 domains replaced by 
a leucine zipper lacked condensed RNPs and contained an increased proportion of 
aberrant core morphologies 49. Consistent with our maturation model, a role for HIV-1 
integrase (IN) in initiating core morphogenesis and viral RNP incorporation into the 
mature core has been recently suggested, and IN has emerged as a maturation 
determinant 50,51. The effect of IN may explain the apparent paradox that in vitro 
digestion of PR- virions results in 1/3 of CA being pelletable, while there was only ~5% 
for in vitro assembled particles, owing to the presence of Pol in PR- virions and perhaps 
additional virion-associated host factors. Our model also explains the observed potent 
trans-dominant effect of uncleavable Gag on viral infectivity, where 4% of Gag with 
MA-CA linker resulted in a 50% decrease in infectivity 16,52,53. The presence of even a 
few such Gag subunits that remain attached to the membrane would preclude CA lattice 
sheet detachment, thus inhibiting capsid formation and leading to a disproportionate drop 
in infectivity. Furthermore, in our in vitro maturation system, the maturation inhibitor 
BVM not only blocked cleavage of CA-SP1, but also partially protected the MA-CA 
cleavage site. The immature lattice-stabilizing effect of BVM has been previously 
observed in cryoET studies 21 and is reflected in our new combinatory capsid maturation 
pathway model. Our model also explains the predominance of conical vs. cylindrical 
structures. We find that any asymmetry developed in the growing lattice due to 
interaction with the membrane or genome (Fig. 5), or due to the shape of initial immature 
lattice creates conical capsids, as opposed to cylindrical shells (Supplementary Fig. 6). 
While many aspects of the HIV-1 maturation process remain to be explored, our 
combined biochemical, structural and computational study allows us to integrate our new 
findings with many previous observations into a new model for HIV-1 maturation. Our 
model of initial displacive rearrangement from immature Gag followed by growth to the 
mature capsid, reconciles most of the current experimental evidence and provides a new 
pathway to elucidate novel therapeutic targets for preventing virion maturation and 
subsequent infectivity. Moreover, the novel in vitro maturation systems that we 
established in this study will be useful for many researchers to dissect the mechanisms of 
retrovirus maturation and to test the effects of maturation inhibitors on this process. 
 Methods 
Protein expression and purification 
The cDNA encoding gag polyprotein, Pr55Gag was obtained from the NIH AIDS 
Research and Reference Reagent Program, Division of AIDS, NIAID, NIH 54. To 
generate Gag (DMA15-100Dp6), plasmid Prr400 encoding corresponding Gag regions was 
subcloned into pET21 (EMD chemicals, Inc. San Diego, CA) using NdeI and XhoI sites. 
Proteins were expressed in E. coli, Rosetta 2 (DE3), cultured in Luria-Bertani media or 
modified minimal medium, and induced with 0.5mM IPTG at 23°C for 16h. All the 
mutants were constructed from pET21 Prr400 with site-direct mutagenesis.  
Cell pellets were collected and resuspended in Lysis buffer (25mM Tris, pH7.5, 
0.5M NaCl, 1µM ZnSO4, and 10mM 2-Mercaptoethanol) and broken with a 
microfludizer. Subsequently, 0.11× total volume of 10% polyethyleneimine (pH8.0) was 
added to precipitate nucleic acids. The lysate was then centrifuged at 35,000 g for 30 min, 
and the pellet discarded. To the supernatant was added ammonium sulfate to 60% 
saturation, on ice, with stirring for 2hr. The solution was then centrifuged at 10,000 g for 
30 min. The pellet was resuspended in lysis buffer and dialyzed overnight against dialysis 
buffer (25mM Tris, pH7.5, 50mM NaCl, 1µM ZnSO4, and 10mM 2-Mercaptoethanol). 
The supernatant was loaded to ion-exchange chromatography (MonoS 10/100 GL column, 
GE Healthcare, Piscataway, NJ), using 50mM-1M NaCl in 25mM Tris, pH7.5, 1µM 
ZnSO4, and 10mM 2-Mercaptoethanol. The final purification step for all proteins 
comprised size-exclusion chromatography (Hi-Load Superdex 200 26/60 column, GE 
Healthcare, Piscataway, NJ) in 25mM Tris, pH7.5, 0.15M NaCl, 1µM ZnSO4, and 10mM 
2-Mercaptoethanol. Proteins were concentrated to 4mg mL-1 using Amicon concentrators 
(Millipore, Billerica, MA), flash-frozen with liquid nitrogen and stored at −80°C. 
 
In vitro Gag VLP assembly 
Protein at 4 mg mL-1 in storage buffer was mixed with yeast tRNA at a nucleic 
acid/protein ratio of 10% (wt/wt), and slowly diluted to 1.5 mg mL-1 by dropwise addition 
of 50 mM sodium acetate (pH6.0), 100 µM ZnSO4, and 5 mM DTT. The mixture was 
then incubated at 10ºC overnight. 
 
Isolation of PR-deficient immature virions 
Immature HIV-1 cores were isolated from particles produced by transfection of 
293T cells with the PR-inactive HIV-1 proviral clone R9.PR- 55. Supernatants from 
transfected 293T cells were filtered through a 0.45 µm pore-size filter to remove cellular 
debris, and particles were pelleted by ultracentrifugation (120,000 xg for 3 hr at 4˚C 
using Beckman rotor SW32Ti) through a cushion of 20% sucrose in PBS buffer. The 
viral pellet was resuspended in 250 µL of STE buffer (10 mM Tris-HCl, 100 mM NaCl, 1 
mM EDTA, pH 7.4) and incubated on ice for 2 hr prior to ultracentrifugation (120,000 ×g 
for 16 hr at 4°C) through a 0.5 ml layer of 1% Triton X-100 into a 10 ml linear gradient 
of 30% to 70% sucrose in STE buffer. Immature cores were recovered from fractions 8 
and 9 of the gradient, corresponding to the known density of retroviral cores. Aliquots of 
the immature core-containing fractions were flash frozen in liquid nitrogen and thawed 
once for use in PR digestion assays.  For cryoEM studies, the immature cores were 
prepared for use without freezing.  
 In vitro cleavage of immature virions and Gag VLPs 
Frozen aliquots of purified cores from PR-deficient particles were thawed, and 
50-100 ng of cores was added to 50 µL reactions containing 100mM NaOAc, 100mM 
NaCl, 1mM EDTA, 1mM DTT, at the indicated pH and concentrations of recombinant 
HIV-1 PR (kind gift from Dr. Celia Schiffer, University of Massachusetts). Reactions 
were incubated at 37°C and stopped by the addition of 20 µM of HIV-1 PR inhibitor 
(Crixivan). A fraction (~66%) of each reaction was removed, diluted to 200 µl in reaction 
buffer lacking PR, and pelleted by centrifugation (45,000 rpm for 30 min at 4°C in a 
Beckman TLA-55 rotor). Pellets were dissolved and subjected to 12% SDS-PAGE and 
immunoblotting with CA-specific mouse monoclonal antibody 183-H12-5C.  For 
cryoEM studies, PR digestion reactions were performed in 200 µl volumes containing 
1500 ng of immature cores. For the cryoEM studies shown in Figure 2 panels a-c, PR-
deficient HIV-1 particles were concentrated by pelleting through a 20% sucrose cushion 
without detergent exposure, resuspended in STE buffer, and used in PR digestion 
reactions in the presence and absence of Triton X-100. Alternatively, PR-deficient 
immature HIV-1 particles were treated with 0.02% Triton X-100 in PR digestion 
reactions. 
PR digestion experiments with recombinant VLPs were performed by addition of 
various concentrations of PR to the Gag assembly mixture, and incubated at 37°C for 2hr. 
For kinetic analysis of Gag cleavage, 3.3 µM of HIV-1 PR was added to the Gag 
assembly mixture and incubated at 37°C; at different time points, 25 µl of the digestion 
reaction mixtures was taken out and put on ice to stop the reaction, and then subjected to 
SDS-PAGE and cryoEM analysis. The cleavage products were separated by NuPAGE 
Novex 4-12% Bis-Tris gel (Invitrogen) and visualized by Coomassie blue staining. 
 
Incubation with maturation inhibitor 
Gag assemblies at different pH values (pH7.4 and pH6.0) were incubated with 40 
µM BVM (kind gift of Chin-Ho Chen, Duke University) and 3.3 µM HIV-1 PR at 37 ºC 
for 2hr. Then 2 µl of the whole sample was mixed with loading buffer, separated by 
NuPAGE Novex 4-12% Bis-Tris gel (Invitrogen) and visualized by Coomassie blue 
staining. The same samples were processed for cryoEM analysis.  
 
CryoEM specimen preparation and data collection 
Gag assemblies with or without PR cleavage were applied (4 µl) to the carbon 
side of a glow discharged perforated Quantifoil grid (Quantifoil Micro Tools, Jena, 
Germany). The grids were then manually blotted with a filter paper from the backside, to 
remove the excess fluid, and plunge-frozen in liquid ethane using a home-made manual 
gravity plunger. For cryoEM imaging, the frozen grids were loaded into a cryo-holder 
(Gatan Inc., Pleasanton, CA) and inserted into a Tecnai F20 transmission electron 
microscope (FEI, Inc., Hillsboro, OR) and imaged with a 2k×2k charge-coupled device 
camera (Gatan). Low dose (10~20 e−/Å2) projection images were collected at a nominal 
magnification of 50,000 with a pixel size of 4.52 Å and underfocus values of 
approximately 5.0 µm.  
 
 
3D reconstruction of helical tubes 
Well-ordered long straight tubes from Gag cleavage samples were Fourier 
transformed and indexed for helical symmetry. Two tubes belonging to the same helical 
family (-14, 11) were included in the final reconstruction. In total, 333 segments of 
130×130 were boxed out for image processing, and 3D helical refinement and 
reconstruction were carried out as previously described 41. During the refinement, helical 
symmetry and contrast transfer function correction were applied. The UCSF Chimera 
package was employed for 3D visualization and isosurface rendering 56. The resolution of 
the final 3D reconstruction was estimated to be 28/22 Å at the 0.5/0.143 thresholds 
respectively, from the gold standard Fourier shell correlation (FSC) curve. 
 
Cryo-electron tomography and sub-tomogram averaging of VLPs 
Gag VLP assemblies (4 µl) were applied to the carbon side of glow discharged 
perforated R2/2 Quantifoil grids and quickly mixed with 1 µl of a 10 nm fiducial gold 
bead solution before plunge-freezing using a manual gravity plunger. Tomography tilt 
series were collected at a nominal magnification of 59,000 × (effective pixel size of 1.9 Å) 
on a Tecnai G2 Polara electron microscope operated at 300 kV. A series of images were 
recorded on an FEI Falcon II direct electron detector by tilting the specimen from -45° to 
55° in increments of 3° tilt angles.  Altogether 34 images were collected in one tilt series 
with a dose of ~30 e- Å-2.  Images were recorded at a defocus value of 4-5 µm using FEI 
batch tomography software. 
Eight tilt series were corrected for the phase inversions due to the Contrast 
Transfer Function (CTF) using a tile based approach, and subsequently aligned and 
reconstructed using weighted-back-projection in IMOD 57. We selected 28 Gag VLPs for 
further processing from the resulting tomograms. To extract sub-tomograms 
corresponding to the Gag lattice, initial positions respective to a Cartesian grid defined by 
each tomogram, were approximated by using a template matching algorithm 
implemented in Matlab with a reference derived from the previous published immature 
structure low-pass filtered to 6nm (EMD-2706) 5. This resolution as well as a coarse 
angular search were chosen to eliminate any statistical correlation of high resolution 
information between half data sets in later image processing steps. Following template 
matching and sub-tomogram extraction, which we limited to the top scoring 300 sub-
tomograms from each VLP, the data were randomly split into two groups of ~ 4,200 sub-
tomograms each, which were processed independently for all subsequent steps. Each sub-
tomogram was iteratively aligned to the average from its respective half-set by using 
standard cross-correlation based methods. After eliminating the lowest scoring sub-
tomograms, the remaining half-sets had ~ 2,000 Gag-hexamers each, with the Fourier 
Shell Correlation (FSC) between them reaching 23.2/18.4A at the 0.5/0.143 thresholds 
respectively. 
 
Computer model building 
Computer simulations were performed based on a model that we had previously 
developed and employed to successfully explain the in vitro formation of conical 
structures in the absence of membrane and genome as well as the defective structures 
observed in the in vivo experiments 46. Simulations based upon these previous works 
were designed to test the impact of the genome and the virion membrane on the 
formation of conical shells and to investigate the different maturation pathways. 
The building blocks of both mature and immature shells were modeled as 
triangular subunits because they can pack to form hexagonal sheets in flat space 44-46 
similar to the Gag and CA molecules.  The difference between immature and mature 
capsids in our model is presented in the mechanical properties of the subunits forming the 
triangular lattice. It is modeled as an elastic sheet that has an associated bending energy 
resulting from deforming it away from its preferred curvature, and a stretching energy 
that comes from distorting the shape of the triangles in the mesh. The bending energy is 
modeled as simple torsional springs between all neighboring triangles, 
Eb = kb
<ij>
∑ (1− cos(θij −θ0 ))with the sum over all neighboring triangles < ij > , kb  a 
torsional spring constant. The quantityθij  is the angle between the normal vectors, and θ0  
is the equilibrium angle between the triangles. We can relate θ0  to the spontaneous radius 
of curvature R0  for the capsid sheet as sin(θ0 / 2) = (12R02 / b02 −3)−1/2 . The stretching energy 
corresponds to a network of springs, Es =
ks
2a=1
3
∑
i
∑ (bia − b0 )2 with the sum over all subunits 
i  in the mesh, bia  is the length of the ath  bond, and b0  the equilibrium bond length.  
The equilibrium shape of the capsid sheet is found by allowing the mesh to relax 
to its minimum energy configuration. This is done numerically using a non-linear 
conjugate gradient method 58. The minimum of the total energy of the mesh depends on 
only two dimensionless constants, the ratio of the linear and torsional spring constants 
also called the Foppl von Karman number γ = b0
2k s
kb
, and the equilibrium angle between 
the triangles θ0 . The shape of the final shells formed depends upon the values of γ  and
R0 , and previous work has explored the parameter space and mapped out the types of 
shells formed 44,45.  The results we are presenting in this paper correspond to one single 
γ  and R0  where we obtain cylindrical and conical shells rather than spherical or irregular 
46,59. These two dimensionless parameters define the material properties of the elastic 
sheet. In the next section we briefly explain our growth model. 
 
Computer simulations: Nucleation and growth 
The assembly of a shell was modeled through the sequential, irreversible addition 
of a triangular subunit to an incomplete shell (Supplementary Fig. 8). After each 
assembly step, the shell is relaxed, assuming that the mean time between additions is 
much larger than the elastic relaxation time. This corresponds to a physical situation in 
which each new subunit will be added to the optimal position, i.e., the number of newly 
formed bonds is maximized and the elastic energy is minimized. Due to the number of 
bonds formed after addition of each subunit, we consider the process is irreversible 44,45, 
once a pentamer or hexamer formed, they can no longer dissociate.  
During the growth process, if there is a location with 5 triangles attached, two 
exposed edges can either join to create a pentamer or a new triangle can be inserted to 
form a hexamer (Supplementary Fig. 8a). As the shell grows and gradually starts to roll, 
the two distance edges of the shell can become close together. If the distance between the 
edges is very small, they merge to mimic the hydrophobic interaction between the 
subunits at the edge (Supplementary Movie 1). 
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Figure 1. In vitro maturation of HIV-1 by protease (PR) cleavage.  (A&B) Digestion of 
immature HIV-1 particles with recombinant HIV-1 PR at 37°C. (A) Reactions were performed 
with 1 μM PR at the indicated pHs.  (B) Reactions were performed at pH 7.4 with 4 μM PR the 
presence or absence of 2 μM bevirimat (BVM). Protein products were immunoblotted with a 
CA-specific antibody and the bands labeled accordingly. (C-E) Cleavage of in vitro assembled 
Gag VLPs at pH 6.0, at various PR concentrations for 2 hr (C), different times of incubation 
with 3.3 μM PR (D), and in the presence or absence of BVM (40 μM) at pH 7.4 and pH 6.0 
with 3.3 μM PR for 2 hr (E). Protein products were visualized by Coomassie blue staining and 
are labeled accordingly. Molecular weight markers are shown on the left. The protein 
designated "MA" contains a large internal deletion (15-100) in Gag VLPs. Samples labeled 
with “*” were subjected to cryoEM analysis, as shown in Fig. 2.
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Figure 2. CryoEM analysis of HIV in vitro maturation by PR cleavage.  (A-C) CryoEM images 
of PR-deficient HIV-1 immature virions before Triton X-100 treatment (A), after Triton X-100 
treatment without HIV-1 PR (B), and after Triton X-100 treatment but with PR at 3.3 μM, pH 6 
for 2hrs (C). The inset in (A) shows an enlarged view of immature virion, with an arrow pointing 
to the immature Gag lattice portion. The inset in (B) shows a Triton X-100 treated virion in 
which part of the membrane was still intact and part was punctured. Intact and perforated virial 
membranes are labeled with black arrowheads and black arrows in B, respectively. The inset 
in (C) shows an enlarged view of a virion after PR cleavage, with a red arrow pointing to the 
ordered lattice of the cleavage product. (D-I) CryoEM images of in vitro maturation of Gag 
VLPs. Low (D-F) and high (G-I) magnification cryoEM images show Gag VLPs morphology 
changes from spheres (D&G) to cones and tubes after 0.33μM (E&H) or 3.3μM (F&I) PR 
treatment for 2 hours. Scale bars, 100 nm in A, C and G, 1 µm in D.
a b c
Figure 3. 3D reconstruction of Gag VLPs before and after PR cleavage. (A-C) The cryoEM 
image (A) and the subtomogram averaged 3D map (B and C) of Gag VLPs before PR 
cleavage. The resulting map is contoured at 1.5V, with immature CA lattice (PDB code 4USN, 
yellow) docked into the density map, viewed along (B) and perpendicular to (C) the radial 
direction. (D&E) The cryoEM image and 3D reconstruction of the tubular structures present 
after PR cleavage of VLPs. The resulting map is contoured at 1.5V, and colored radially from 
yellow to blue. (F&G) Fitting of mature CA hexamer (PDB code 3J34, yellow) into the density 
map, viewed from tube surface (F) and along the tube axis (G). The map is contoured at 1.5V. 
The mature CA hexamer, not the immature, docks well into the EM density map. The inner 
layer density (seen in G) is likely the cleaved NC protein. Scale bars, 100 nm.
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Figure 4. CA association following Gag cleavage by PR. (A) Immunoblot analysis of PR-
treated immature virions in the presence of bevirimat (BVM) where indicated. PR-negative 
immature virions were digested with 1 μM PR at 37qC for varying amounts of time, up to 4 hrs. 
Particles were pelleted after digestion and CA association with core was monitored by 
immunoblotting with CA-specific mouse monoclonal antibody. (B) Effect of the capsid-
destabilizing mutation K203A on CA association following Gag cleavage. Purified cores from 
PR-defective particles with wild type (wt) or K203A mutant CA were treated and analyzed as in 
(A). (C) Effect of CAP-1 on CA association during in vitro maturation. Cores from PR-deficient 
HIV-1 particles were treated as in (A) in the presence of 20 μM capsid assembly inhibitor CAP-
1 for 2.5 hrs, then analyzed as in (A). (D) Effect of cleavage mutants on CA association during 
in vitro maturation by PR digestion of Gag VLPs. Supernatant (s) and pellet (p) of cleavage 
products following 3.3 μM PR digestion at 37qC for 2hrs, analyzed by SDS-PAGE gel and 
visualized by Coomassie Blue staining. The corresponding cleavage products are labeled. 
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Figure 5. Role of membrane and genome in the formation of mature core. (a) Formation of open 
tube in a free environment. (b) The presence of membrane (the grey sphere) limits the size of the 
cylinder. Membrane can also facilitate formation of pentamers resulting into the formation of 
cones. (c) During the assembly process, if the genome (ball) remains attached to a few subunits, 
a conical capsid forms. Otherwise, a cylindrical shell assembles with genome remaining outside, 
see the movie in Supplementary Material.
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Figure 6. Formation of a conical capsid through a combination of displacive and 
disassembly/reassembly models. Initially a lattice formed from 600 subunits detaches from 
the membrane. The lattice undergoes maturation (steps 1-5), i.e., the mechanical properties 
and the spontaneous curvature of lattice transforms from an immature capsid to a mature 
one.
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Figure 7. A model for different HIV-1 maturation pathways. Top figure shows an immature 
shell composed of a membrane (blue circle), MA proteins (orange balls), CA proteins (purple 
balls), NC proteins (green balls) and RNA (the red line). Column A shows the fully displacive 
model in which the detached immature lattice undergoes maturation. Column B illustrates 
the sequential combination of displacive and assembly model. A portion of the immature 
lattice undergoes maturation followed by addition of CA proteins to the growing edge.  
Column C indicates the disassembly and de novo reassembly model. The immature lattice 
completely disassembles and then the disassembled CA proteins assemble de novo.
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Supplementary Figure 1. Maturation intermediates by in vitro protease cleavage of Gag 
VLPs. (a) A typical Gag VLP before PR cleavage.  (b) Formation of the mature core after PR 
treatment. (c) A gallery of “hybrid” entities resulting from incomplete maturation process. 
Shown are the changes from spherical immature surfaces to sharply curved surfaces. The 
images were recorded from the same sample in Fig. 1c labeled “*2”. All panels are on the 
same scale. Scale bar, 100 nm.
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dSupplementary Figure 2. (a) Fourier Shell Correlation (FSC) of the 3D density maps of 
Gag spheres (black) and post-cleavage tubular products (grey). (b) Fitting of immature CA 
lattice (PDB code 4USN) into the Gag sphere density map, shown in slice-views along the 
radial direction. (C&D) Fitting of immature CA lattice (PDB code 4USN) into the tube density 
map, viewed from tube surface (c) and along the tube axis (d). The maps are contoured at 
1.5 V. 
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Supplementary Figure 3. Formation of a conical capsid. The genome and a few subunits 
remain attached to the membrane at the beginning of the growth process. 
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Supplementary Figure 4. Snapshots of formation of a conical capsid through a 
combination of displacive and disassembly/reassembly models. Initially a lattice formed 
from 400 hundred subunits detaches from the membrane. The lattice undergoes 
maturation, i.e., the mechanical properties and the spontaneous curvature of lattice 
transforms from an immature capsid to a mature one. The orange ball illustrates the 
genome.
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Supplementary Figure 5. Snapshots of formation of a conical capsid through a 
combination of displacive and disassembly/reassembly models in the absence of 
membrane but the presence of genome.
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Supplementary Figure 6. The role of initial condition and symmetry in the final 
structure of capsids.  If the initial lattice has hexagonal symmetry, a cylindrical shell 
forms (a); otherwise a conical capsid forms (b).
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Supplementary Figure 7. Relative frequency of cone formation in simulations under the 
indicated conditions: in the absence of membrane and genome (red); in the presence of 
membrane but absence of genome (blue); and in the presence of both membrane and 
genome (green). 
Supplementary Figure 8. (a) Formation of a pentamer or hexamer depends on the opening 
angle. Five assembled subunits can either become a pentamer or a new subunit can be 
added to them to become a hexamer. (b) The step by step growth of a shell by addition of 
triangular subunits.
(a) (b)
Number of CA subunits that 
initially transform from an 
immature lattice to the mature 
lattice without disassembly 
Absence of 
membrane and 
genome 
Presence of 
membrane but 
absence of 
genome
Presence of both 
membrane and 
genome
disassembly/reassembly
1 subunit 37% 52% 83%
displacive + reassembly
24 subunits 53% 88%
100 subunits 53% 89%
400 subunits 0% 100%
600 subunits 0%* 40%**
Supplementary Table 1: Percentage of cones in total number of capsids (cones+cylinders).
*Rolling sheet.
**Some cones are defective.
